Adenovirus receptors.
作者信息
Zhang Yuanming, Bergelson Jeffrey M
机构信息
Division of Infectious Diseases, Children's Hospital of Philadelphia, PA, USA.
出版信息
J Virol. 2005 Oct;79(19):12125-31. doi: 10.1128/JVI.79.19.12125-12131.2005.
Abstract
摘要
相似文献
1
Adenovirus receptors.腺病毒受体
J Virol. 2005 Oct;79(19):12125-31. doi: 10.1128/JVI.79.19.12125-12131.2005.
2
CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7.CD46是除3型和7型之外所有B组腺病毒的细胞受体。
J Virol. 2005 Nov;79(22):14429-36. doi: 10.1128/JVI.79.22.14429-14436.2005.
3
Viral attachment strategies: the many faces of adenoviruses.病毒附着策略：腺病毒的多面性。
Curr Opin Virol. 2011 Aug;1(2):84-91. doi: 10.1016/j.coviro.2011.05.024. Epub 2011 Jun 30.
4
Circulation of incorrectly labeled adenovirus 50 and 51 prototype preparations.错误标记的腺病毒50型和51型原型制剂的流通情况。
J Clin Microbiol. 2006 Sep;44(9):3468. doi: 10.1128/JCM.01288-06.
5
Extent of circulation of incorrectly labeled adenovirus 50 and 51 prototype preparations.错误标记的腺病毒50型和51型原型制剂的传播范围。
J Clin Microbiol. 2007 Jun;45(6):2092; discussion 2092. doi: 10.1128/JCM.00251-07.
6
Analysis of adenoviruses isolated in Kobe City, Japan, from 2000 to 2007.
Jpn J Infect Dis. 2008 Nov;61(6):503-4.
7
What does it take to bind CAR?结合嵌合抗原受体（CAR）需要什么？
Mol Ther. 2005 Oct;12(4):599-609. doi: 10.1016/j.ymthe.2005.05.017.
8
[Progress in the Development of Animal Models Supporting Human Adenovirus Infection].[支持人类腺病毒感染的动物模型开发进展]
Bing Du Xue Bao. 2016 Nov;32(6):810-6.
9
Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan.日本新型人腺病毒 54 型引起的流行性角膜结膜炎的流行病学和病毒学特征。
Br J Ophthalmol. 2011 Jan;95(1):32-6. doi: 10.1136/bjo.2009.178772. Epub 2010 Jun 8.
10
Genome typing of adenovirus type 34 isolated in two cases of conjunctivitis in Sapporo, Japan.对在日本札幌两例结膜炎病例中分离出的34型腺病毒进行基因组分型。
J Clin Microbiol. 2001 Nov;39(11):4187-9. doi: 10.1128/JCM.39.11.4187-4189.2001.
引用本文的文献
1
Identification and characterization of a novel human adenovirus type HAdV-D116.新型人类腺病毒HAdV-D116的鉴定与特性分析
Front Microbiol. 2025 May 7;16:1566316. doi: 10.3389/fmicb.2025.1566316. eCollection 2025.
2
Atomic force microscopy at the forefront: unveiling foodborne viruses with biophysical tools.前沿的原子力显微镜：利用生物物理工具揭示食源病毒
Npj Viruses. 2025 Apr 4;3(1):25. doi: 10.1038/s44298-025-00107-y.
3
Four decades of adenovirus gene transfer vectors: History and current use.腺病毒基因转移载体四十年：历史与当前应用
Mol Ther. 2025 May 7;33(5):2192-2204. doi: 10.1016/j.ymthe.2025.03.062. Epub 2025 Apr 2.
4
Construction of a bivalent vaccine candidate against HAdV4/HAdV7 based on capsid-display strategy via Red-homologous recombination and counter-selection methodology.基于Red同源重组和反选择方法通过衣壳展示策略构建针对人腺病毒4型/人腺病毒7型的二价候选疫苗。
Biosaf Health. 2024 Feb 7;6(2):70-79. doi: 10.1016/j.bsheal.2024.02.001. eCollection 2024 Apr.
5
Chimeric Ad5/35 oncolytic adenovirus overcome preexisting neutralizing antibodies and enhance tumor targeting efficiency.嵌合型Ad5/35溶瘤腺病毒可克服预先存在的中和抗体并提高肿瘤靶向效率。
Cancer Gene Ther. 2025 Apr;32(4):418-436. doi: 10.1038/s41417-025-00884-x. Epub 2025 Mar 8.
6
Virus-Receptor Interactions and Receptor-Mediated Virus Entry into Host Cells.病毒-受体相互作用以及受体介导的病毒进入宿主细胞
Subcell Biochem. 2024;105:533-566. doi: 10.1007/978-3-031-65187-8_15.
7
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients.溶瘤病毒：多发性骨髓瘤患者潜在的免疫治疗突破。
Front Immunol. 2024 Oct 30;15:1483806. doi: 10.3389/fimmu.2024.1483806. eCollection 2024.
8
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy.改造溶瘤病毒以增强癌症免疫疗法的策略。
Front Pharmacol. 2024 Sep 6;15:1450203. doi: 10.3389/fphar.2024.1450203. eCollection 2024.
9
Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.用于患者来源的胰腺癌培养物中溶瘤病毒治疗疗效的生物标志物筛选。
EBioMedicine. 2024 Jul;105:105219. doi: 10.1016/j.ebiom.2024.105219. Epub 2024 Jun 27.
10
Expanding the Scope of Adenoviral Vectors by Utilizing Novel Tools for Recombination and Vector Rescue.利用新型重组和载体拯救工具扩展腺病毒载体的范围。
Viruses. 2024 Apr 23;16(5):658. doi: 10.3390/v16050658.
本文引用的文献
1
Localization of regions in CD46 that interact with adenovirus.CD46中与腺病毒相互作用区域的定位。
J Virol. 2005 Jun;79(12):7503-13. doi: 10.1128/JVI.79.12.7503-7513.2005.
2
The B7 family revisited.重新审视B7家族。
Annu Rev Immunol. 2005;23:515-48. doi: 10.1146/annurev.immunol.23.021704.115611.
3
Adenovirus structure.腺病毒结构。
Hum Gene Ther. 2004 Dec;15(12):1167-76. doi: 10.1089/hum.2004.15.1167.
4
The structure of the human adenovirus 2 penton.人类腺病毒2型五聚体的结构
Mol Cell. 2005 Jan 7;17(1):121-35. doi: 10.1016/j.molcel.2004.11.041.
5
Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs.删除五邻体RGD基序会影响含有5型或35型腺病毒纤维钮的病毒颗粒的内化效率和从内体逃逸的效率。
J Virol. 2005 Jan;79(2):1053-61. doi: 10.1128/JVI.79.2.1053-1061.2005.
6
Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.用D亚组纤维假型化的5型腺病毒载体在体外和体内表现出改变的嗜性。
Hum Gene Ther. 2004 Nov;15(11):1054-64. doi: 10.1089/hum.2004.15.1054.
7
Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection.糖萼在体外和体内限制腺病毒载体与呼吸道上皮细胞上表达的顶端受体结合：锚定黏蛋白作为管腔感染屏障的作用。
J Virol. 2004 Dec;78(24):13755-68. doi: 10.1128/JVI.78.24.13755-13768.2004.
8
Adenoviruses as vaccine vectors.腺病毒作为疫苗载体。
Mol Ther. 2004 Oct;10(4):616-29. doi: 10.1016/j.ymthe.2004.07.013.
9
The identification of an adenovirus receptor by using affinity capture and mass spectrometry.
Chembiochem. 2004 Aug 6;5(8):1095-9. doi: 10.1002/cbic.200400037.
10
Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.5型腺病毒纤维蛋白和五聚体修饰对大鼠体内嗜性的影响。
Mol Ther. 2004 Aug;10(2):344-54. doi: 10.1016/j.ymthe.2004.05.020.
Zotero 插件